Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04820751
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:14.228340+00:00
Published At
2021-04-02T00:00:00+00:00
Record Updated At
2021-04-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Viral Pneumonia", "Serotonin Syndrome", "Platelet Dysfunction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-04-02"
protocolSection.identificationModule.nctId
"NCT04820751"
protocolSection.identificationModule.officialTitle
"Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Viral Pneumonia (protocolSection.conditionsModule.conditions)
  • Serotonin Syndrome (protocolSection.conditionsModule.conditions)
  • Platelet Dysfunction (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.